Last 7 days
-4.5%
Last 30 days
-10.7%
Last 90 days
-5.3%
Trailing 12 Months
16.7%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
SYK | 104.1B | 18.4B | 2.26% | 8.00% | 44.16 | 5.64 | 7.84% | 18.25% |
ISRG | 84.2B | 6.2B | -4.47% | -13.27% | 63.66 | 13.53 | 8.97% | -22.43% |
BSX | 69.1B | 12.7B | 0.59% | 12.45% | 99.06 | 5.45 | 6.68% | -32.95% |
BDX | 67.4B | 19.0B | -5.16% | -6.78% | 41.86 | 3.55 | -0.43% | -8.78% |
EW | 49.8B | 5.4B | 2.41% | -25.12% | 32.74 | 9.26 | 2.86% | 1.25% |
MID-CAP | ||||||||
PEN | 10.2B | 847.1M | -3.64% | 34.52% | -5.1K | 12.05 | 13.32% | -137.89% |
INSP | 7.4B | 407.9M | -10.70% | 16.71% | -163.98 | 18.04 | 74.75% | -6.75% |
GMED | 5.2B | 1.0B | -11.64% | -20.31% | 30.19 | 5.09 | 6.76% | 24.45% |
IRTC | 3.5B | 410.9M | 4.51% | -3.13% | -29.82 | 8.43 | 27.29% | -14.60% |
OMCL | 2.5B | 1.3B | 1.97% | -58.05% | 451.35 | 1.97 | 14.48% | -92.74% |
SMALL-CAP | ||||||||
SDGR | 1.7B | 181.0M | 12.30% | -10.66% | -11.1 | 9.15 | 31.19% | -48.60% |
AVNS | 1.3B | 820.0M | -8.35% | -12.22% | 25.89 | 1.59 | 10.13% | 701.59% |
ICAD | 33.3M | 29.3M | -34.48% | -66.75% | -2.27 | 1.14 | -19.35% | -69.01% |
HTGM | 2.7M | 6.8M | -26.89% | 55.78% | -0.12 | 0.4 | -21.00% | -36.01% |
Income Statement (Last 12 Months) | ||||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 17.1% | 407,856,000 | 348,354,000 | 300,851,000 | 262,424,000 | 233,394,000 |
Gross Profit | 16.5% | 341,741,000 | 293,235,000 | 256,894,000 | 225,122,000 | 200,115,000 |
Operating Expenses | 13.7% | 389,333,000 | 342,313,000 | 298,574,000 | 265,339,000 | 239,965,000 |
S&GA Expenses | 12.7% | 320,688,000 | 284,622,000 | 252,262,000 | 224,273,000 | 202,615,000 |
R&D Expenses | 19.0% | 68,645,000 | 57,691,000 | 46,312,000 | 41,066,000 | 37,350,000 |
EBITDA | 11.6% | -40,733,000 | -46,066,000 | -40,105,000 | -38,939,000 | - |
EBITDA Margin | 24.5% | -0.10 | -0.13 | -0.13 | -0.15 | - |
Earnings Before Taxes | 11.3% | -44,268,000 | -49,914,000 | -43,657,000 | -42,371,000 | -41,970,000 |
EBT Margin | 24.3% | -0.11 | -0.14 | -0.15 | -0.16 | - |
Interest Expenses | -24.3% | 1,677,000 | 2,215,000 | 2,096,000 | 2,132,000 | 2,128,000 |
Net Income | 11.0% | -44,881,000 | -50,422,000 | -43,922,000 | -42,520,000 | -42,042,000 |
Net Income Margin | 24.0% | -0.11 | -0.14 | -0.15 | -0.16 | - |
Free Cahsflow | 118.1% | 2,473,000 | -13,645,000 | -22,624,000 | -27,028,000 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 7.1% | 565 | 528 | 292 | 290 | 295 |
Current Assets | 7.0% | 530 | 496 | 263 | 262 | 269 |
Cash Equivalents | 5.7% | 442 | 418 | 187 | 203 | 214 |
Inventory | -21.5% | 12.00 | 15.00 | 22.00 | 22.00 | 17.00 |
Net PPE | 22.0% | 17.00 | 14.00 | 11.00 | 9.00 | 8.00 |
Liabilities | 20.1% | 69.00 | 57.00 | 65.00 | 65.00 | 66.00 |
Current Liabilities | 24.1% | 61.00 | 49.00 | 47.00 | 43.00 | 41.00 |
Shareholder's Equity | 5.5% | 496 | 470 | 227 | 225 | 229 |
Retained Earnings | 1.0% | -324 | -327 | -310 | -296 | -279 |
Additional Paid-In Capital | 2.8% | 820 | 798 | 538 | 521 | 508 |
Shares Outstanding | 0.7% | 29.00 | 29.00 | 28.00 | 28.00 | 27.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | 266.1% | 12.00 | -6.97 | -18.31 | -22.47 | -20.12 |
Share Based Compensation | 18.1% | 52.00 | 44.00 | 36.00 | 30.00 | 26.00 |
Cashflow From Investing | -14.1% | -19.60 | -17.18 | 17.00 | 29.00 | 29.00 |
Cashflow From Financing | 1.4% | 235 | 232 | 12.00 | 14.00 | 15.00 |
88.3%
70.8%
29.6%
Y-axis is the maximum loss one would have experienced if Inspire Medical Systems was unfortunately bought at previous high price.
54.8%
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-15 | B. Riley Wealth Advisors, Inc. | reduced | -12.18 | 67,312 | 343,312 | 0.01% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -33.45 | -2,771,990 | 47,631,000 | 0.05% |
2023-03-10 | BAILLIE GIFFORD & CO | unchanged | - | 11,805 | 40,805 | -% |
2023-03-06 | Rockefeller Capital Management L.P. | added | 18.52 | 91,000 | 225,000 | -% |
2023-02-28 | Voya Investment Management LLC | added | 413 | 21,095,500 | 24,450,500 | 0.04% |
2023-02-24 | NATIXIS | added | 54.00 | 2,196,350 | 4,166,350 | 0.02% |
2023-02-22 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | new | - | 602,000 | 602,000 | 0.01% |
2023-02-21 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | added | 375 | 12,358 | 14,358 | -% |
2023-02-21 | MACQUARIE GROUP LTD | reduced | -24.66 | 17,372,000 | 267,162,000 | 0.32% |
2023-02-17 | TRUIST FINANCIAL CORP | reduced | -20.29 | 301,312 | 2,587,310 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 10.31% | 2,978,391 | SC 13G/A | |
Jan 31, 2023 | blackrock inc. | 7.4% | 2,135,708 | SC 13G/A | |
Nov 10, 2022 | vanguard group inc | 10.04% | 2,899,902 | SC 13G/A | |
Feb 03, 2022 | blackrock inc. | 6.7% | 1,846,227 | SC 13G/A | |
Jan 10, 2022 | fmr llc | - | 0 | SC 13G/A | |
Feb 12, 2021 | orbimed advisors llc | 0.00% | 0 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 8.92% | 2,401,971 | SC 13G | |
Feb 08, 2021 | fmr llc | - | 0 | SC 13G/A | |
Feb 02, 2021 | blackrock inc. | 7.4% | 1,993,714 | SC 13G |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 8.17 -96.78% | 12.73 -94.98% | 30.42 -88.01% | 60.76 -76.05% | 121.35 -52.17% |
Current Inflation | 7.83 -96.91% | 11.86 -95.33% | 27.20 -89.28% | 53.06 -79.09% | 104.43 -58.84% |
Very High Inflation | 7.40 -97.08% | 10.81 -95.74% | 23.40 -90.78% | 44.12 -82.61% | 85.00 -66.50% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 13, 2023 | 4 | Insider Trading | |
Mar 13, 2023 | 4/A | Insider Trading | |
Mar 13, 2023 | 4/A | Insider Trading | |
Mar 10, 2023 | 4 | Insider Trading | |
Mar 03, 2023 | 4 | Insider Trading | |
Feb 28, 2023 | 4 | Insider Trading | |
Feb 21, 2023 | 4 | Insider Trading | |
Feb 14, 2023 | 4 | Insider Trading | |
Feb 14, 2023 | 4 | Insider Trading | |
Feb 14, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-08 | Rondoni John | acquired | 9,081 | 2.07 | 4,387 | chief technology officer |
2023-03-01 | Ban Randy | sold | -83,531,100 | 8,353 | -10,000 | chief commercial officer |
2023-03-01 | Ban Randy | acquired | 9,400 | 0.94 | 10,000 | chief commercial officer |
2023-02-27 | Jandrich Steven | gifted | - | - | 128 | vp, human resources |
2023-02-27 | Jandrich Steven | gifted | - | - | -128 | vp, human resources |
2023-02-24 | Jandrich Steven | gifted | - | - | -256 | vp, human resources |
2023-02-24 | Jandrich Steven | gifted | - | - | 128 | vp, human resources |
2023-02-16 | Ebeling Philip | sold | -1,925,000 | 275 | -7,000 | chief operating officer |
2023-02-16 | Ebeling Philip | acquired | 1,363,740 | 194 | 7,000 | chief operating officer |
2023-02-15 | Herbert Timothy P. | sold | -3,223,620 | 275 | -11,715 | ceo and president |
Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Income Statement [Abstract] | ||||
Revenue | $ 109,188 | $ 61,685 | $ 269,956 | $ 154,996 |
Cost of goods sold | 19,786 | 8,624 | 43,963 | 22,123 |
Gross profit | 89,402 | 53,061 | 225,993 | 132,873 |
Operating expenses: | ||||
Research and development | 20,993 | 9,614 | 47,397 | 27,056 |
Selling, general and administrative | 85,603 | 53,243 | 225,853 | 143,846 |
Total operating expenses | 106,596 | 62,857 | 273,250 | 170,902 |
Operating loss | (17,194) | (9,796) | (47,257) | (38,029) |
Other expense (income): | ||||
Interest and dividend income | (1,350) | (22) | (1,681) | (110) |
Interest expense | 656 | 537 | 1,677 | 1,590 |
Other expense, net | 101 | 33 | 290 | 90 |
Total other (income) expense | (593) | 548 | 286 | 1,570 |
Loss before income taxes | (16,601) | (10,344) | (47,543) | (39,599) |
Income taxes | 246 | 3 | 488 | 52 |
Net loss | (16,847) | (10,347) | (48,031) | (39,651) |
Other comprehensive loss: | ||||
Foreign currency translation loss | (148) | 0 | (106) | 0 |
Unrealized (loss) gain on investments | (14) | 3 | (202) | (38) |
Total comprehensive loss | $ (17,009) | $ (10,344) | $ (48,339) | $ (39,689) |
Net loss per share, basic (in dollars per share) | $ (0.60) | $ (0.38) | $ (1.73) | $ (1.46) |
Net loss per share, diluted (in dollars per share) | $ (0.60) | $ (0.38) | $ (1.73) | $ (1.46) |
Weighted average common shares used to compute net loss per share, basic (in shares) | 28,226,345 | 27,300,377 | 27,782,093 | 27,225,499 |
Weighted average common shares used to compute net loss per share, diluted (in shares) | 28,226,345 | 27,300,377 | 27,782,093 | 27,225,499 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Sep. 30, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 417,808 | $ 214,467 |
Investments, short-term | 9,741 | 0 |
Accounts receivable, net of allowance for credit losses of $34 and $99, respectively | 48,498 | 34,179 |
Inventories | 15,146 | 17,231 |
Prepaid expenses and other current assets | 4,351 | 2,660 |
Total current assets | 495,544 | 268,537 |
Investments, long-term | 0 | 9,938 |
Property and equipment, net | 14,134 | 8,486 |
Operating lease right-of-use assets | 7,141 | 7,919 |
Other non-current assets | 10,704 | 204 |
Total assets | 527,523 | 295,084 |
Current liabilities: | ||
Accounts payable | 20,305 | 11,665 |
Accrued expenses | 28,986 | 20,454 |
Notes payable, current portion | 0 | 9,188 |
Total current liabilities | 49,291 | 41,307 |
Notes payable, non-current portion | 0 | 15,799 |
Operating lease liabilities, non-current portion | 7,882 | 8,796 |
Other non-current liabilities | 146 | 134 |
Total liabilities | 57,319 | 66,036 |
Stockholders' equity: | ||
Preferred Stock, $0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding | 0 | 0 |
Common Stock, $0.001 par value per share; 200,000,000 shares authorized; 28,820,680 and 27,416,106 issued and outstanding at September 30, 2022 and December 31, 2021, respectively | 29 | 27 |
Additional paid-in capital | 797,958 | 508,465 |
Accumulated other comprehensive loss | (363) | (55) |
Accumulated deficit | (327,420) | (279,389) |
Total stockholders' equity | 470,204 | 229,048 |
Total liabilities and stockholders' equity | $ 527,523 | $ 295,084 |